Disease management programs in type 2 diabetes: Quality of care

American Journal of Managed Care

Volumn 17, Issue 6, 2011, Pages 393-403

  Berthold, Heiner K ^a   Bestehorn, Kurt P ^b   Jannowitz, Christina ^b   Krone, Wilhelm ^c   Gouni Berthold, Ioanna ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MSD Sharp and Dohme GmbH   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN TREATMENT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; GERMANY; HUMANS; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); OUTPATIENTS; PATIENT EDUCATION AS TOPIC; QUALITY OF HEALTH CARE; SMOKING;

EID: 79960209995     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-234. (Pubitemid 28350165)
2. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness - which ones work? meta-analysis of published reports. BMJ. 2002;325(7370):925.
3. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24(10):1821-1833. (Pubitemid 33716489)
4. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev. 2001;(1):CD001481.
5. Kesteloot K. Disease management: a new technology in need of critical assessment. Int J Technol Assess Health Care. 1999;15(3):506-519. (Pubitemid 29466183)
6. Pilnick A, Dingwall R, Starkey K. Disease management: definitions, difficulties and future directions. Bull World Health Organ. 2001;79(8):755-763. (Pubitemid 32776845)
7. Busse R. Disease management programs in Germany's statutory health insurance system. Health Aff (Millwood). 2004;23(3):56-67.
8. Nagel H, Baehring T, Scherbaum WA. Implementing disease management programs for type 2 diabetes in Germany. Manag Care. 2006;15(11):50-53.
9. Valk GD, Renders CM, Kriegsman DM, et al. Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs. Health Serv Res. 2004;39(4, pt 1):709-725. (Pubitemid 38924675)
10. Rieser S. Disease-Management-Programme ...und sie wirken doch! Deutsches Ärzteblatt. 2009;106(34-35):B1417-B1418.
11. Beyer M, Gensichen J, Szecsenyi J, Wensing M, Gerlach FM. Effectiveness of German disease management programs - problems of clinical evaluation research in the light of a study protocol [in German]. Z Arztl Fortbild Qualitatssich. 2006;100(5):355-363. (Pubitemid 44186754)
12. Pimouguet C, Le GM, Thiébaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ. 2011;183(2):E115-E127.
13. Del Prato S. Megatrials in type 2 diabetes: from excitement to frustration? Diabetologia. 2009;52(7):1219-1226.
14. Gouni-Berthold I, Berthold HK, Mantzoros CS, Böhm M, Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2008;31(7):1389-1391.
15. Bestehorn K, Jannowitz C, Karmann B, Pittrow D, Kirch W. Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry. BMC Public Health. 2009;9:280.
16. Krone W, Böhm M. Diabetes mellitus needs unrestricted evaluation of patient data to yield treatment progress. The DUTY Register [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004;47(6):540-546.
17. Berthold HK, Gouni-Berthold I, Bestehorn KP, Böhm M, Krone W. Physician gender is associated with the quality of type 2 diabetes care. J Intern Med. 2008;264(4):340-350.
18. Berthold H, Gouni-Berthold I, Bestehorn K, Böhm M, Krone W. Cardiovascular risk factors in patients with type 2 diabetes in Germany. Deutsches Ärzteblatt. 2007;104(13):A861-A867.
19. Berthold HK, Gouni-Berthold I, Böhm M, Krone W, Bestehorn KP. Patterns and predictors of statin prescription in patients with type 2 diabetes. Cardiovasc Diabetol. 2009;8:25.
20. Federal Ministry of Justice. Requirements for structured care programs for type 2 diabetes [Anforderungen an strukturierte Behandlungsprogramme für Diabetes mellitus Typ 2]. Bundesgesetzblatt. 2002;I(42):2290-2297.
21. American Diabetes Association. Executive summary: standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S4-S10.
22. Catenacci VA, Hill JO, Wyatt HR. The obesity epidemic. Clin Chest Med. 2009;30(3):415-444, vii.
23. West R. Tobacco control: present and future. Br Med Bull. 2006;77-78:123-136. (Pubitemid 46092277)
24. Cooper JG, Claudi T, Jenum AK, et al. Quality of care for patients with type 2 diabetes in primary care in Norway is improving: results of cross-sectional surveys of 33 general practices in 1995 and 2005. Diabetes Care. 2009;32(1):81-83.
25. Campbell SM, Roland MO, Middleton E, Reeves D. Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study. BMJ. 2005;331(7525):1121.
26. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care. 2008;31(1):81-86.
27. Dulal RK, Karki S. Disease management programme for diabetes mellitus in Nepal. JNMA J Nepal Med Assoc. 2009;48(176):281-286.
28. Butler MK, Kaiser M, Johnson J, Besse J, Horswell R. Diabetes mellitus disease management in a safety net hospital system: translating evidence into practice. Popul Health Manag. 2010;13(6):319-324.
29. Stock S, Drabik A, Büscher G, et al. German diabetes management programs improve quality of care and curb costs. Health Aff (Millwood). 2010;29(12):2197-2205.
30. Stock SA, Redaelli M, Lauterbach KW. Disease management and health care reforms in Germany - does more competition lead to less solidarity? Health Policy. 2007;80(1):86-96.
31. Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A. German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument. Diabetes Care. 2008;31(6):1150-1154.
32. Joos S, Rosemann T, Heiderhoff M, Wensing M, et al. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct - a study protocol [ISRCTN08471887]. BMC Public Health. 2005;5:99.
33. Miksch A, Laux G, Ose D, et al. Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care. 2010;16(1):49-54.
34. Stark R, Schunk M, Leidl R, Meisinger C, Holle R. Prozessevaluation von Disease Management Programmen bei Typ 2 Diabetes auf Basis einer bevölkerungsrepräsentativen Studie in der Region Augsburg (KORA). Betriebswirtschaftliche Forschung und Praxis. 2009;61(283):301.
35. Knight K, Badamgarav E, Henning JM, et al. A systematic review of diabetes disease management programs. Am J Manag Care. 2005;11(4):242-250. (Pubitemid 40569747)
36. Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ. 2009;338:b1870.
37. Grundy SM, Cleeman JI, Merz CN, et al; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44(3):720-732.
38. Rutan GH, McDonald RH, Kuller LH. A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. J Clin Epidemiol. 1989;42(7):663-673. (Pubitemid 19190647)
39. Safar ME. Pulse pressure, arterial stiffness and wave reflections (augmentation index) as cardiovascular risk factors in hypertension. Ther Adv Cardiovasc Dis. 2008;2(1):13-24. (Pubitemid 351583139)
40. Lawes CM, Bennett DA, Parag V, et al; Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension. 2003;42(1):69-75.
41. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913. (Pubitemid 35472129)
42. Kengne AP, Czernichow S, Huxley R, et al; ADVANCE Collaborative Group. Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension. 2009;54(2):399-404.
43. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006;49(8):1761-1769. (Pubitemid 44025030)
44. Gaede P, Pedersen O. Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis. Diabetes. 2004;53(suppl 3):S39-S47. (Pubitemid 39564521)
45. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296(4):427-440. (Pubitemid 44127527)
46. O'Connor PJ, Crabtree BF, Abourizk NN. Longitudinal study of a diabetes education and care intervention: predictors of improved glycemic control. J Am Board Fam Pract. 1992;5(4):381-387.
47. Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2009;(1):CD005268.
48. Jacobs K, Häussler B. Disease management im künftigen Kassenwettbewerb. Gesundheit und Gesellschaft Wissenschaft. 2002;2(1):24-31.
49. Schäfer I, Küver C, Gedrose B, et al. The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences. BMC Health Serv Res. 2010;10:55.